Stephen J. Hill serves as Executive at Lyell Immunopharma, Inc., where they oversee executive responsibilities. Since joining the company, Stephen J. Hill has executed 9 insider transactions totaling $16.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 10, 2026 involved receiving (via award) 65,000 shares valued at $0.
Stephen J. Hill currently holds 65,000 shares of Lyell Immunopharma, Inc. (LYEL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen J. Hill has been a net seller of LYEL stock. They have purchased $0 and sold $16.6K worth of shares.
Stephen J. Hill's most recent insider trade was on Feb 10, 2026, when they sold 65,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $23.12 |
| Discretionary |
| Feb 9, 2026 | LYEL | $0 | Award | 4,000 | $N/A | Discretionary |
| Nov 10, 2025 | LYEL | $1.5K | Sale | 95 | $16.12 | Discretionary |
| Aug 21, 2025 | LYEL | $10.6K | Sale | 1,004 | $10.54 | Discretionary |
| Aug 20, 2025 | LYEL | $0 | Award | 8,000 | $N/A | Discretionary |
| Aug 12, 2025 | LYEL | $972 | Sale | 94 | $10.34 | Discretionary |
| Aug 11, 2025 | LYEL | $958 | Sale | 91 | $10.53 | Discretionary |
| Feb 9, 2024 | LYEL | $0 | Award | 40,000 | $N/A | Discretionary |